Почетна › Рак плућа › Konektikat
Kliničke studije za Рак плућа u državi Konektikat
32 studija za Рак плућа traži učesnike na lokacijama u državi Konektikat.
Gradovi u državi Konektikat
- New Haven24 студија
- Bridgeport13 студија
- East Norwalk11 студија
- Stamford10 студија
- Hartford10 студија
- Waterbury6 студија
- New London5 студија
Zvanični tekst studije (na engleskom)
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Hartford HealthCare - Avon, Avon
- Hartford Hospital, Hartford
- Hartford HealthCare - Manchester, Manchester
- и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06498635Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich
- и још 9
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Stamford Hospital/Bennett Cancer Center, Stamford
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven
Тражи се учесникФаза 3
Узраст 70 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06096844A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Stamford Hospital ( Site 0083), Stamford
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06312137A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Hartford Hospital, Hartford
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06793215Phase 1 Study of PF-08046033 in Advanced Solid Tumors
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- и још 2
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07519655Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich
- и још 12
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT04181060VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Hartford Hospital (site 210), Hartford
Тражи се учесникФаза 1/2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT03556228SI-B036-ST-101 in Advanced/Metastatic Solid Tumors
- Yale Cancer Center, New Haven
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07857616A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Yale University School of Medicine, New Haven
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06287775Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
- Yale University, New Haven
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06014827A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Yale Cancer Center, New Haven
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06172478Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Research Site, New Haven
Тражи се учесникФаза 2
Узраст од 18 до 95 · Оба пола · Ажурирано 21. 10. 2026. · NCT05061550AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, New Haven
Тражи се учесникФаза 1/2
Узраст од 18 до 75 · Оба пола · Ажурирано 16. 10. 2026. · NCT07038343Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Yale University School of Medicine - Yale Cancer Center, New Haven
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT05786924Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
- и још 10
Тражи се учесникФаза 2
18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich
- и још 9
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Yale Cancer Center, New Haven
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Yale Cancer Center, New Haven
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 17. 9. 2026. · NCT07349537Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- Yale Cancer Center, New Haven
- Norwalk Hospital, Norwalk
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT06343402Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, New Haven
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 3. 8. 2026. · NCT05433142A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Yale University Cancer Center, New Haven
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 15. 7. 2026. · NCT05652686Integrated Cancer Repository for Cancer Research
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 19 до 110 · Оба пола · Ажурирано 29. 6. 2026. · NCT02012699Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Smilow Cancer Hospital (Yale University), New Haven
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT06040541Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
- и још 11
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT05642572Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
- Yale New Haven Medical Center, New Haven
Тражи се учесникЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 5. 3. 2026. · NCT06196008SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
- Yale School of Medicine, New Haven
Тражи се учесникОпсервациона студија
Узраст од 18 до 99 · Оба пола · Ажурирано 12. 8. 2025. · NCT06412172Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Stamford Hospital, Stamford
Тражи се учесникОпсервациона студија
Узраст 50 и старији · Оба пола · Ажурирано 5. 8. 2025. · NCT06122077Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
- Trinity Health Of New England, Hartford
- The Stamford Health/The Stamford Hospital, Stamford
Тражи се учесникОпсервациона студија
Узраст од 29 до 85 · Оба пола · Ажурирано 13. 11. 2024. · NCT06426628Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.